Toxoplasma’s Arms Race with the Host Interferon Response: A Ménage à Trois of ROPs  by Zhao, Yanlin & Yap, George S.
Cell Host & Microbe
PreviewsToxoplasma’s Arms Race
with the Host Interferon Response:
A Me´nage a` Trois of ROPsYanlin Zhao1 and George S. Yap1,*
1Center for Immunity and Inflammation and Department of Medicine, New Jersey Medical School, Rutgers, the State University of
New Jersey, Newark, NJ 07101, USA
*Correspondence: yapgs@njms.rutgers.edu
http://dx.doi.org/10.1016/j.chom.2014.05.002
The Toxoplasma gondii virulence factors ROP5 and ROP18 both target immunity-related GTPases (IRGs)
to evade immunity. In this issue of Cell Host & Microbe, Etheridge et al. (2014) identify a third virulence factor,
ROP17, which forms a complex and synergizes with ROP5/ROP18 to fully disable the IRG system of antipar-
asite defense.Toxoplasma gondii is a protozoan para-
site transmitted asexually through the
food chain through carnivorous feeding
in wild and domesticated animals, but
the parasite also undergoes a well-
defined sexual cycle exclusively in felines.
Rodents, being the natural prey of cats,
are considered to be important intermedi-
ate hosts for the parasite, while infections
occurring in humans, although clinically
important in the context of acquired im-
munodeficiency or congenital transmis-
sion, represent a dead end for the para-
site’s transmission cycle.
Beginning with genetic studies pio-
neered by David Sibley in the early
1990s, progress in unraveling the genetic
and molecular basis for the virulence of
T. gondii in the laboratory mouse has,
in the recent decade, gained great mo-
mentum. Using crosses generated be-
tween highly virulent type I or intermediate
virulence type II and avirulent type III
parental parasites, genetic mapping ana-
lyses identified an active rhoptry kinase,
ROP18, and an enzymatically inactive
pseudokinase, ROP5, as principal deter-
minants of T. gondii virulence (Reese
et al., 2011; Saeij et al., 2006). A key set
of ROP18 kinase substrates belong to
the family of immunity-related GTPases
or IRGs (Fentress et al., 2010). During
the Th1-dominated immune response
to T. gondii, IFNg greatly induces expres-
sion of IRGs, which associate with the
nascent parasitophorous vacuole mem-
brane (PVM) formed by the parasite
following invasion. In host cells infected
with nonvirulent strains, which express
low levels of ROP18, loading of IRGsthrough a yet to be determined receptor(s)
on the PVM somehow results in the vesic-
ulation and physical disruption of the
PVM and subsequent death of the para-
site (Zhao et al., 2009). However, in the
case of virulent strains, ROP18 phosphor-
ylates specific residues in switch region I
of the GTPase domain of IRGs, inactivat-
ing enzymatic activity, IRG oligomeriza-
tion, and assembly on the PVM (Steinfeldt
et al., 2010). Although the type II strain
expresses a ROP18 allele capable of
increasing virulence in the type III strain,
the PVMs formed by type II parasites are
permissive for IRG loading and are sus-
ceptible to this IFNg-induced cellular
defense mechanism. This observation
indicated that interactions with another
gene present in the virulent type I or the
avirulent type III strain are needed for
immune evasion.
Subsequent studies identified and
characterized another virulence locus
that encodes the polymorphic pseudoki-
nase ROP5, which is similar between
type I and type III strains but distinct
in type II strains and helped explain
how the Toxoplasma virulence-associ-
ated evasion mechanism works optimally
in vivo. The virulence-associated allele of
ROP5 interacts with IRGs, favoring the
inactive GDP-dependent conformation
of the IRGs (Fleckenstein et al., 2012).
Association of IRGs with ROP5 also ex-
poses the target threonines located in
the switch I loop for ROP18 phosphory-
lation. In vitro studies also provided
evidence that interaction with the ROP5
pseudokinase enhances the kinase
activity of ROP18 (Behnke et al., 2012).Cell Host & MicrobeAltogether, these data are consistent
with the genetic evidence that ROP5
and ROP18 operated along the same
pathway to target IRGs and act to fore-
stall destruction of the PVM. However,
the fact that deletion of ROP18 in the
virulent type I background only resulted
in slight attenuation, while ROP5 defi-
ciency results in complete loss of ability
to cause lethal infection in mice, raised
the question of whether ROP5 regulated
the activity of additional virulence factors.
Deletion of either ROP5 or ROP18 alone
resulted in approximately the same levels
of IRG loading and type I parasite
destruction in IFNg-activated macro-
phages, suggesting that the putative
ROP5-dependent actors may promote
virulence independently of the ROP18-
mediated evasion of IRG clearance of
the parasite.
To identify additional ROP5-regulated
virulence effectors, Etheridge et al.
(2014) utilized tandem affinity purification
of native complexes containing ROP5.
Mass spectrometry analysis identified
ROP18 as well as a new ROP kinase,
ROP17. Examination of the sequences
of ROP17 indicated a shared allele be-
tween avirulent type II and type III strains
and a unique type I sequence. Similar
to ROP18, ROP17 contains a conserved
catalytic triad that predicted active
serine/threonine kinase activity. The ki-
nase activity of native ROP5- or ROP17-
containing complexes was greater
compared to recombinant ROP17 alone,
suggesting the presence of additional
enhancing factors in vivo. Nevertheless,
the enzyme activity of native ROP1715, May 14, 2014 ª2014 Elsevier Inc. 517
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the presence of ROP5.
Genetic deletion of ROP17, similar to
the case of ROP18, resulted in only slight
attenuation of virulence. Deletion of both
ROP17 and ROP18, however, generated
parasites that are completely avirulent.
Nevertheless, ROP17/ROP18 double
mutants regained their lethality in mice
lacking the IRG lrgm3, suggesting the sur-
prising conclusion that ROP17 may also
be operating in the same IRG pathway
targeted by ROP18. Using a positional-
scanning peptide array to construct a
probability matrix motif for ROP17, it
was determined that ROP17 preferred to
phosphorylate Thr102 in the switch region
I of IRGs, while the ROP18 motif centered
on Thr108. This differential preference
was confirmed experimentally using MS
analysis of phosphorylation sites in the
Irgb6 protein incubated with ROP17.
Using native gel analysis of lrgb6 protein
incubated with GTP to promote oligomer-
ization, Etheridge et al. (2014) demon-
strated that ROP17 preferred phosphory-
lation of polymerized IRGs and suggested
that phosphorylation leads to disassem-
blage of the IRG polymers accumulating
on the PVM. Given the likelihood that
assembled complexes of ROPs exposed
on the surface of the PVM are highly
heterogeneous, it is uncertain how the
observed preference for Thr102 versus
Thr108 or for different members of the
IRG family translates in vivo. Neverthe-
less, given previous findings that both
residues are critical for enzyme activity
and for oligomerization, the authors pro-
pose a model where ROP17 and ROP18
together phosphorylate and prevent as-
sembly of IRGs on the PVM. They further518 Cell Host & Microbe 15, May 14, 2014 ª2suggest a scenario where phosphoryla-
tion of polymerized IRGs by ROP17would
lead to generation of monomeric sub-
strates for ROP5-ROP18 complexes.
Even though the in vitro activation
of ROP17 appears to be independent
of ROP5, complexation of ROP17 with
ROP5 will likely facilitate IRG-sub-
strate localization and indirectly lead to
enhanced ROP17 activity in vivo.
The current discovery of the tripartite
ROP5:ROP18:ROP17 virulence complex
that appears to principally target the
mouse-specific IRG system underscores
the importance of rodents in the life cycle
of Toxoplasma. Paradoxically, virulence
leads to lethality while avirulence will
result in persistence and transmission in
nature. Recently, the Howard laboratory
in Cologne reported a very interesting
analysis of the IRG system in wild
mice, which revealed a great degree of
complexity and polymorphism rivaling
that observed for the MHC (Lilue et al.,
2013). They also discovered a wild-
derived CIM mouse strain, which is resis-
tant to T. gondii strains that are typically
lethal for laboratory mice. In this wild-
derived mouse, a divergent IRG, desig-
nated as lrgb2-b1CIM, binds to ROP5
and itself becomes a target for the
ROP5-ROP18 complex, but blocks the
phosphorylation of effector IRGs, leading
to destruction of the parasite vacuole.
In this case, the mouse immune sys-
tem has been selected to resist virulent
T. gondii strains to allow encystment and
latency. However, the same virulent
strains have a disadvantage when infect-
ing less resistant mouse strains (exempli-
fied by laboratory mice). Given the loss of
the IRG system in primates (Bekpen et al.,014 Elsevier Inc.2005), it is unlikely that same counter-reg-
ulatory mechanisms are operative when
Toxoplasma infects humans.ACKNOWLEDGMENTS
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